Hazardous Drug Sample Analysis
Defense Health Agency · DEFENSE HEALTH AGENCY
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT942726QE008 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
As part of the DCPH-A mission, the Lab Sciences (LS) Directorate requires the analysis of wipe/swab samples for the presence of hazardous drugs in support of pharmacies and Military Treatment Facilities (MTFs) within the Department of War (DoW). This analysis is mandated for the MTFs using Chemotherapy drugs to ensure their cleaning procedures are effective to ensure safety of the MTF staff and to avoid cross-contamination. The directives that mandate this semi-annual testing requirement are United Stated Pharmacopiea (USP) 800: Handling Hazardous Drugs and Technical Bulletin-Medical (TB-MED) … (show all)
515: Occupational Health and Indutrial Hygiene Guidance for the Management, Use and Disposal of Hazardous Drugs. There is no acceptable level of occupational exposure to Hazardous Drugs. The LS Directorate of the DCPH-A is the only government laboratory to perform this hazardous drugs analysis as required. While LS does have the analytical capability to perform hazardous drugs analyses, as a sole source for this effort, there is a need to have back-up laboratory capability for instances of instrument down-time or over-capacity situations. Objectives for this Requirement are as follows: The Contractor shall perform analysis on wipe/swab samples provided by the Government for Hazardous Drugs contamination. The Contractor shall perform the sample analysis within the stated turnaround time (TAT) identified in the Outsource Document and identified in the PWS. The Contractor shall provide Quality wipe/swab analysis for various hazardous drugs as identified in this PWS in accordance with an accredited methodology. The Contractor shall dispose of unused samples as prescribed by their quality manual/Standing Operating Procedures and return Government shipping containers. The Contractor shall supply sampling media upon request. The Contractor shall pay liquidated damages for late or deficient reporting as detailed in Section 5.of the PWS. QUESTIONS are due by 20 April 2026 by 1pm Eastern Standard Time (EST) QUOTATIONS are due by 24 April 2026 by 11am EST. See the Performance Work Statement (PWS) for complete information regarding this effort.
Who won similar work
4 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY), same product/service code (PSC) Q301.
Single-winner award sizes (4): middle half $453K to $3.5M, median $1.9M; range $328K to $4.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BLOODWORKS Seattle WA 98104 USA | 1 | $4.0M | Oct 1, 2026 |
| SOPHIA GENETICS, INC. | 1 | $3.4M | Sep 26, 2025 |
| BROOKS APPLIED LABS LLC | 1 | $494K | Sep 23, 2026 |
| I-2-I Solutions, Inc. | 1 | $328K | Dec 10, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 1, 2026BLOODWORKS Seattle WA 98104 USA$4.0MBlood Donor Testing ServicesNo listed company matched (Materiality N/A)
- Sep 23, 2026BROOKS APPLIED LABS LLC$494KTrace Metal Sample AnalysisNo listed company matched (Materiality N/A)
- Dec 10, 2025I-2-I Solutions, Inc.$328KAward Water TestingNo listed company matched (Materiality N/A)
- Sep 26, 2025SOPHIA GENETICS, INC.$3.4MBioinformatics at Keesler Air Force BaseNo listed company matched (Materiality N/A)
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (0 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.